Thromboprophylaxis in Germany;Prophylaxe tiefer bein- und beckenvenenthrombose

Deutsches Arzteblatt

Volumn 104, Issue 42, 2007, Pages 2886-2893

  Moerchel, Christian ^a   Kroeger, Knut ^b  

^a Praxis für Allgemeinmedizin   (Germany)

^b UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

Deep vein thrombosis; Heparin; Mortality; Prophylaxis; Pulmonary embolism

Indexed keywords

HEPARIN;

ANTICOAGULATION; BUDGET; CERTIFICATION; GERMANY; HEALTH CARE QUALITY; HEALTH SERVICE; HOSPITAL BED; HOSPITALIZATION; HUMAN; INCIDENCE; LUNG EMBOLISM; MEDICAL EDUCATION; MEDICAL PRACTICE; OUTPATIENT CARE; PRACTICE GUIDELINE; PREVALENCE; PRIMARY MEDICAL CARE; REVIEW; RISK ASSESSMENT; THROMBOPHLEBITIS;

EID: 35648945875     PISSN: 00121207     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (24)

1. Dentali F, Douketis JD, Gianni M, Lim W, Crowther MA: Meta-analysis: anticoagulant prophylaxis to prevent symptomatic venous thromboembolism in hospitalized medical patients. Ann Intern Med 2007; 146: 278-88.
2. Encke A, Haas S, Krauspe R, Riess H et al.: Stationäre und ambulante Thromboembolieprophylaxe in der Chirurgie und der perioperativen Medizin Interdisziplinäre Leitlinie. Phlebologie 2003; 32: 164-9.
3. Niermann I: Anschlussheilbehandlung: "Blutige Entlassung" verlagert Kosten in die Reha. Dtsch Arztebl 2007; 104(14): A 923-6.
4. Merten M: Krankenhausentlassungen: Hausarzt bleibt außen vor. Dtsch Arztebl 2004; 101(24): A 1707-8.
5. Ulsenheimer K: Gutachterliche Aspekte der Thromboseprophylaxe. Chirurg 2007; 78: 133-7.
6. Oger E: Incidence of venous thromboembolism: a community-based study in Western France. EPI-GETBP Study Group. Groupe d'Etude de la Thrombose de Bretagne Occidentale. Thromb Haemost 2000; 83: 657-60.
7. Heit JA, Melton LJ 3rd, Lohse CM1 Petterson TM, Silverstein MD, Mohr DN, O'Fallon WM: Incidence of venous thromboembolism in hospitalized patients versus community residents. Mayo Clin Proc 2001; 76: 1102-10.
8. Partsch H, Blättler W: Aktualisierte Fassung Leitlinien zur Thromboembolie-Prophylaxe. Phlebologie 2000; 29: 106-13.
9. Meignan M, Rosso J, Gauthier H, Brunengo F, Claudel S, Sagnard L, d'Azemar P, Simonneau G, Charbonnier B: Systematic lung scans reveal a high frequency of silent pulmonary embolism in patients with proximal deep venous thrombosis. Arch Intern Med. 2000; 160: 159-64.
10. Partsch H: Therapy of deep vein thrombosis with low molecular weight heparin, leg compression and immediate ambulation. Vasa 2001; 30: 195-204.
11. Douketis JD, Kearon C, Bates S, Duku EK, Ginsberg JS: Risk of fatal pulmonary embolism in patients with treated venous thromboembolism. JAMA 1998; 279: 458-62.
12. Murray DW, Britton AR, Bulstrode CJ: Thromboprophylaxis and death after total hip replacement. J Bone Joint Surg Br 1996; 78: 863-70.
13. Lutz L, Haas S et al.: Venöse Thromboembolie in der Inneren Medizin: Risikoeinschätzung und medikamentöse Prophylaxe. Med Welt 2002; 53: 231-4.
14. Chopard P, Dorffler-Melly J, Hess U, Wuillemin WA, Hayoz D, Gallino A, Bachli EB, Canova CR, Isenegger J, Rubino R, Bounameaux H: Venous thromboembolism prophylaxis in acutely ill medical patients: definite need for improvement. J Intern Med 2005; 257: 352-7.
15. Hill J, Treasure T: Reducing the risk of venous thromboembolism (deep vein thrombosis and pulmonary embolism) in patients having surgery: summary of NICE guidance. BMJ 2007; 334: 1053-4.
16. Kierkegaard A, Norgren L: Graduated compression stockings in the prevention of deep vein thrombosis in patients with acute myocardial infarction. Eur Heart J 1993; 14: 1365-8.
17. Nationale Versorgungsleitlinie chronische KHK. Dtsch Arztebl 2006; 103(44): A2968-73.
18. Samama MM, Cohen AT, Darmon JY et al.: A comparison or enoxaparin with placebo for the prevention of venous thrombembolism in acutely ill medical patients. N Engl J Med 1999; 341: 793-800.
19. Cohen AT, Davidson BL, Gallus AS, Lassen MR, Prins MH, Tomkowski W, Turpie AG, Egberts JF, Lensing AW; ARTEMIS Investigators: Efficacy and safety of fondaparinux for the prevention of venous thromboembolism in older acute medical patients: randomised placebo controlled trial. BMJ 2006; 332: 325-9.
20. Leizorovicz A, Cohen AT, Turpie AG et al.: Randomized, placebo-controlled trial of dalteparin for the prevention of venous thromboembolism in acutely ill medical patients. Circulation 2004; 110: 874-9.
21. Geerts WH, Pineo GF, Heit JA, Bergqvist D, Lassen MR, Colwell CW, Ray JG: Prevention of Venous Thromboembolism: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 126: S338-400.
22. Nicolaides AN, Breddin HK, Fareed J et al.: Prevention of venous thromboembolism. International Consensus Statement. Guidelines compiled in accordance with the scientific evidence. Int Angiol 2001; 20: 1-37.
23. Monreal M, Kakkar AK, Caprini JA, Barba R, Uresandi F, Valle R, Suarez C, Otero R; RIETE Investigators: The outcome after treatment of venous thromboembolism is different in surgical and acutely ill medical patients. Findings from the RIETE registry. J Thromb Haemost 2004; 2: 1892.
24. Kröger K: Thrombosediagnostik im klinischen Alltag - Ergebnisse einer multizentrischen Erhebung. ZFA 2006; 82: 486-90.